z-logo
open-access-imgOpen Access
Blockade of RAS-Binding Domain Interactions Inhibits RAS Signaling
Publication year - 2016
Publication title -
cancer discovery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.795
H-Index - 163
eISSN - 2159-8290
pISSN - 2159-8274
DOI - 10.1158/2159-8290.cd-rw2016-085
Subject(s) - blockade , signal transduction , domain (mathematical analysis) , microbiology and biotechnology , chemistry , pharmacology , computational biology , biology , cancer research , receptor , biochemistry , mathematical analysis , mathematics
Rigosertib acts as a RAS mimetic, binding to the RAS-binding domain of multiple RAS effector proteins.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom